Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

NCT02268695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

541

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Cisplatin
DRUG: 5-Fluorouracile
DRUG: Docetaxel
DRUG: Cetuximab
DRUG: granulocyte colony-stimulating factor (G-CSF)

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou

Collaborators

[object Object]
[object Object]